Three Modalities of Treatment in Operable and Resectable Stage IIIA (T1-3, N2) Non-Small Cell Lung Cancer (NSCLC)

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2007 by Hospices Civils de Lyon.
Recruitment status was Active, not recruiting

Study NCT00198367 Information provided by Hospices Civils de Lyon

First Received on September 13, 2005. Last Updated on October 4, 2007 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Additional drug interventions recognized in this trial

Gemcitabine
Paclitaxel
Vinorelbine

More general drug interventions related to this trial

Sponsors listed in this trial